Groups

Research Focus

Former Employee. Human Oncology and Pathogenesis Program; Research Associate

Recent additions – View all

1. Engineered tumor-targeted T cells mediate enhanced anti-tumor efficacy both directly and through activation of the endogenous immune system

   Journal Article

   Avanzi, M. P.; Yeku, O.; Li, X.; Wijewarnasuriya, D. P.; van Leeuwen, D. G.; Cheung, K.; Park, H.; Purdon, T. J.; Daniyan, A. F.; Spitzer, M. H.; more...
   Cell Reports (2018)

   Fulltext@MSK | Save
2. Emerging role of CAR T cells in non-Hodgkin's lymphoma

   Journal Article

   Avanzi, M. P.; Brentjens, R. J.
   Journal of the National Comprehensive Cancer Network (2017)

   Fulltext@MSK | Save
3. IL-18 secreting CAR T cells enhance cell persistence, induce prolonged B cell aplasia and eradicate CD19+ tumor cells without need for prior conditioning

   Meeting Abstract

   Avanzi, M. P.; van Leeuwen, D. G.; Li, X.; Cheung, K.; Park, H.; Purdon, T. J.; Brentjens, R. J.
   Blood (2016)

   Fulltext@MSK | Save